Filing Details
- Accession Number:
- 0001181431-13-052152
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-10-02 19:25:29
- Reporting Period:
- 2013-09-30
- Filing Date:
- 2013-10-02
- Accepted Time:
- 2013-10-02 19:25:29
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
861838 | Idera Pharmaceuticals Inc. | IDRA | Biological Products, (No Disgnostic Substances) (2836) | 043072298 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1193366 | El Youssef Zein | Pillar Invest Offshore Sal, Starko Ctr, Bloc B, 3Rd Floor, Omar Daouk Street Beirut M8 2020-3313 | Yes | No | Yes | No | |
1534428 | Pillar Invest Corp | C/O Idera Pharmaceuticals, Inc. 167 Sidney Street Cambridge MA 02139 | Yes | No | Yes | No | |
1588130 | Pillar Pharmaceuticals Iv, L.p. | Pillar Invest Offshore Sal Starco Ctr Bloc B, 3Rd Floor, Omar Daouk Street Beirut M8 2020-3313 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-09-30 | 845,161 | $0.00 | 0 | No | 4 | P | Indirect | See Footnotes |
Common Stock | Acquisiton | 2013-09-30 | 929,032 | $0.00 | 0 | No | 4 | P | Indirect | See Footnotes |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See Footnotes |
No | 4 | P | Indirect | See Footnotes |
Footnotes
- On September 30, 2013, upon the consummation of a public offering of the Issuer (the "Offering"), Pillar Pharmaceuticals IV, L.P. ("Pillar IV"), of which Pillar GP is the general partner, acquired, in the Offering, 845,161 shares of common stock (the "Pillar IV Shares") of the Issuer. Pillar GP disclaims Section 16 beneficial ownership of the Pillar IV Shares and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar IV. As of the date hereof, Pillar IV owns directly 845,161 shares of common stock of the Issuer.
- On September 30, 2013, upon the consummation the Offering, Participations Besancon ("Besancon"), a fund advised by Pillar GP, acquired, in the Offering, 929,032 shares of common stock (the "Besancon Shares"). Pillar GP also disclaims Section 16 beneficial ownership of the Besancon Shares and this report shall not be deemed an admission that Pillar GP is the beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, resulting from fees payable to Pillar GP in its capacity as investment advisor to Besancon. As of the date hereof, Besancon owns directly 3,329,032 shares of common stock of the Issuer.
- Youssef El Zein is a director and controlling stockholder of Pillar GP and serves as the representative of Pillar IV and Pillar GP on the Issuer's board of directors. Mr. El Zein disclaims Section 16 beneficial ownership of the Pillar IV Shares and the Besancon Shares and this report shall not be deemed an admission that he is the beneficial owners of any such securities, except to the extent of his pecuniary interest therein, if any, by virtue of his ownership interest in Pillar GP. As of the date hereof, Mr. El Zein owns directly 586,101 shares of common stock of the Issuer.